Optomed: Adjusted revenue estimates
Research Note
2021-07-13
14:52
Redeye revises slightly its revenue and EBITDA projections for 2021. While we remain conservative in our near-term expectations, we maintain our conviction that Optomed is on the path of spectacular growth.
GA
Gergana Almquist
Disclosures and disclaimers